Urgent.ly stock jumps again in premarket as ULY extends a volatile run
31 December 2025
1 min read

Urgent.ly stock jumps again in premarket as ULY extends a volatile run

NEW YORK, December 31, 2025, 04:26 ET — Premarket

  • Urgent.ly (ULY) was up about 27% in premarket trade after a 52% jump in Tuesday’s regular session. 1
  • The microcap’s latest disclosed update was an SEC filing saying its annual meeting was adjourned for lack of quorum and will reconvene on Jan. 28. 2
  • Heavy volume on Tuesday far exceeded the stock’s typical trading activity, a setup that can amplify price swings. 3

Shares of Urgent.ly Inc surged 26.8% to $3.50 in premarket trading on Wednesday, after the roadside-assistance software provider ended Tuesday up 52.5% at $2.76. 1

The outsized move is drawing attention to Urgent.ly’s thin trading profile and a recent corporate update that reset the clock on a key shareholder vote. That matters now because microcap stocks can gap sharply when order flow concentrates ahead of scheduled events. 3

Urgent.ly said in a Form 8-K — a filing used to disclose major corporate events — that it convened and then adjourned its 2025 annual meeting “due to insufficient votes to constitute a quorum.” A quorum is the minimum shareholder participation required to conduct business. 2

In that filing, signed by Chief Executive Officer Matthew Booth, the company said: “The Annual Meeting will reconvene at 11:00 a.m., Eastern Time, on Wednesday, January 28, 2026.” 2

Tuesday’s rally came on unusually heavy turnover. Urgent.ly has about 2.19 million shares outstanding and a float of roughly 1.95 million shares, according to market data, and it traded more than 8.3 million shares in the regular session — about 20 times its average volume. 3

Beyond the meeting update, there was no new earnings release or product announcement in the latest filing, and the company did not disclose changes to the proposals to be voted on. 2

Urgent.ly operates a mobility assistance platform that connects drivers with service providers for roadside help and related services across automotive and insurance channels, according to its company profile. 4

The price action has been abrupt even by small-cap standards. On Tuesday, ULY opened around $1.87 and traded as high as $3.09 before settling at $2.76, StockAnalysis data showed. 4

The stock is still well below its 52-week high of $17.99, and it has traded as low as $1.74 in the past year, underscoring how quickly sentiment has shifted around the name. 3

For traders, the near-term question is whether Wednesday’s premarket gains hold into the regular session, or fade as liquidity deepens after the open. With a small float, even modest buying or selling can move the price disproportionately. 3

Investors will also watch for any follow-up disclosures ahead of the rescheduled annual meeting, including whether the company can secure sufficient votes to reach a quorum when the meeting reconvenes. 2

Stock Market Today

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

Deutsche Telekom stock slips despite fresh buyback — what matters before earnings

8 February 2026
Deutsche Telekom shares fell 1.1% to 30.26 euros Friday, despite the company repurchasing 250,873 shares for about 7.63 million euros on Xetra. The drop came as European stocks rose and T-Mobile US shares slipped 2.2%. Deutsche Telekom’s 2025 results are due Feb. 26. The company has completed its 2025 buyback and launched a new 2 billion euro programme for 2026.
Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

Airbus stock price ends higher near 191 euros as January deliveries slow, earnings loom

8 February 2026
Airbus shares rose 0.94% to 191.30 euros Friday as the company reported 19 aircraft deliveries in January, down from 25 a year earlier. Supply chain bottlenecks remain an issue, with executives at the Singapore Airshow calling delays “unacceptable.” Jefferies kept a Neutral rating and a 215-euro price target. Airbus will report full-year 2025 results on Feb. 19.
Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades
Previous Story

Vanda Pharma stock jumps premarket after FDA approves Nereus, first new motion-sickness vomiting drug in decades

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring
Next Story

Profusa stock whipsaws: PFSA dips premarket after 78% surge on debt restructuring

Go toTop